Evidence map›Paper›PMID 41116940›Full record

ArticleCureus2025

Pachydermoperiostosis Associated With a Rare SLCO2A1 Mutation: A Case Report and Literature Review.

Maen Mohammad, Yousef Alnajjar, Enas Jondi, Mohammad Alsheikh, Adeeb Darras, Abdullah Hamamdah, Muaath Itmaizeh

Abstract readCase Reports
In one paragraph

Article in Cureus, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Maen MohammadGeneral Practice, Al-Quds University, Jerusalem, PSE.
Yousef AlnajjarInternal Medicine, Al-Makassed Islamic Charitable Society Hospital, Jerusalem, PSE.
Enas JondiInternal Medicine, Al-Quds University, Jerusalem, PSE.
Mohammad AlsheikhInternal Medicine, Al-Makassed Islamic Charitable Society Hospital, Jerusalem, PSE.
Adeeb DarrasInternal Medicine, Al-Makassed Islamic Charitable Society Hospital, Jerusalem, PSE.
Abdullah HamamdahInternal Medicine, Al-Makassed Islamic Charitable Society Hospital, Jerusalem, PSE.
Muaath ItmaizehInternal Medicine, Al-Makassed Islamic Charitable Society Hospital, Jerusalem, PSE.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Pachydermoperiostosis (PDP), also known as primary hypertrophic osteoarthropathy, is a rare genetic disorder characterized by digital clubbing, periostosis, and pachydermia. It typically presents during adolescence or early adulthood and is commonly associated with mutations in the HPGD or SLCO2A1 genes. Due to its nonspecific clinical features, PDP is often misdiagnosed, resulting in delayed treatment. We report the case of a 26-year-old Arab male with an eight-year history of progressive facial skin thickening, hyperhidrosis, and digital clubbing. Laboratory investigations were unremarkable, while imaging revealed periostosis. Genetic analysis identified a SLCO2A1 mutation (c.563A>G, p.Gln188Arg). Our patient experienced significant physical discomfort and psychological distress, with notable improvement following treatment with nonsteroidal anti-inflammatory drugs and corticosteroids. In our review of 246 PDP cases with SLCO2A1 mutations, the c.940+1G>A splice variant was most frequent. PDP shows marked male predominance (92.3%) and is most prevalent in Asian populations, particularly Chinese (53.3%). Most diagnoses occurred between ages ≤25 and 25-45 years. Common manifestations include digital clubbing (82.5%), pachydermia (74.4%), and hyperhidrosis (41.1%), with consanguinity reported in 29.7% of cases. Clinical overlap with rheumatologic and endocrine disorders often delays diagnosis. Genetic confirmation is essential for accurate identification. This case reinforces the importance of considering PDP in patients with unexplained digital clubbing and pachydermia. Early recognition and genetic confirmation of PDP can prevent unnecessary testing and guide effective treatment. Comprehensive, multidisciplinary care, including psychosocial support, is vital to optimize outcomes in this rare genetic disorder.

Indexed as

case reportclubbingpachydermoperiostosisperiostosisprimary hypertrophic osteoarthropathy

Identifiers

PMID41116940
PMCPMC12535772

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.